Corrigendum: Evaluation of the SARS-CoV-2 Inactivation Efficacy Associated With Buffers From Three Kits Used on High-Throughput RNA Extraction Platforms
- PMID: 34956936
- PMCID: PMC8694096
- DOI: 10.3389/fcimb.2021.813442
Corrigendum: Evaluation of the SARS-CoV-2 Inactivation Efficacy Associated With Buffers From Three Kits Used on High-Throughput RNA Extraction Platforms
Abstract
[This corrects the article DOI: 10.3389/fcimb.2021.716436.].
Keywords: PCR; SARS-CoV-2; biosafety; clinical diagnosis; high throughput; laboratory-acquired infection.
Copyright © 2021 Thom, Eastaugh, O’Brien, Ulaeto, Findlay, Smither, Phelps, Stapleton, Hamblin and Weller.
Erratum for
-
Evaluation of the SARS-CoV-2 Inactivation Efficacy Associated With Buffers From Three Kits Used on High-Throughput RNA Extraction Platforms.Front Cell Infect Microbiol. 2021 Sep 16;11:716436. doi: 10.3389/fcimb.2021.716436. eCollection 2021. Front Cell Infect Microbiol. 2021. PMID: 34604108 Free PMC article.
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous